Literature DB >> 2026226

HIV infection in Greek intravenous drug users.

G Papaevangelou1, A Roumeliotou, G Stergioy, A Nestoridou, E Trichopoulou, G Kallinikos, G Rizos, E Kornarou.   

Abstract

In order to investigate the prevalence of HIV infection among Greek intravenous drug users (IVDU), its trend during years recent and possible risk factors, we studied 893 inmates recently admitted to the main prisons of Greece from 1986 to 1989. Screening and counselling was offered to all of them. The acceptance rate was 98%. One thousand one hundred and two IVDUs voluntarily attending the AIDS Reference Centre in Athens for counselling and screening were also included in the study. Anti-HIV were determined by commercially available radioimmunoassays, and positive results were confirmed by Western Blot. Our results showed that the prevalence of HIV infection remained very low in both groups during the study period; it was similar to the prevalence found (2.1%) in stored sera drawn in 1982 from imprisoned IVDU. In the non-prisoner group, the prevalence among those who reported needle/syringe sharing (2.6%) was similar to that among those who denied sharing (2.5%). This lack of difference may be due to the fact that sharing is only an occasional practice and that cleaning of of the injection equipment is common. We conclude that the prevalence of anti-HIV in IVDU in Greece is considerably lower than that in neighbouring countries and that it has remained stable during the last eight years. Further studies are necessary to identify behavioral and other risk factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026226     DOI: 10.1007/bf00221347

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  8 in total

1.  Risk behaviors for HIV transmission among intravenous-drug users not in drug treatment--United States, 1987-1989.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-04-27       Impact factor: 17.586

2.  The epidemiology of licit and illicit substance use among high school students in Greece.

Authors:  A Kokkevi; C Stefanis
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

3.  Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS.

Authors:  J A van den Hoek; H J van Haastrecht; R A Coutinho
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

4.  HTLV-III antibodies in drug addicts in Spain.

Authors:  J M Rodrigo; M A Serra; E Aguilar; J A del Olmo; V Gimeno; L Aparisi
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

5.  HTLV-III antibody among Italian drug addicts.

Authors:  P Ferroni; D Geroldi; C Galli; A R Zanetti; A Cargnel
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

6.  Rapid spread of HTLV-III infection among drug addicts in Italy.

Authors:  G Angarano; G Pastore; L Monno; T Santantonio; N Luchena; O Schiraldi
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

7.  Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece.

Authors:  A Roumeliotou-Karayannis; N Tassopoulos; E Karpodini; E Trichopoulou; M Kotsianopoulou; G Papaevangelou
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

Review 8.  Prevalence of HIV infection among intravenous drug users in the United States.

Authors:  R A Hahn; I M Onorato; T S Jones; J Dougherty
Journal:  JAMA       Date:  1989-05-12       Impact factor: 56.272

  8 in total
  1 in total

1.  Predictive factors of HIV-infection in injecting drug users upon incarceration.

Authors:  V Martín; J A Caylà; M L Morís; L E Alonso; R Pérez
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.